Patents by Inventor Lida WU
Lida WU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
A METHOD FOR INDUCING IPSC DIFFERENTIATION TO OBTAIN CD34+CELLS AND NK CELLS AND APPLICATION THEREOF
Publication number: 20250049847Abstract: The present invention discloses a method and its application for inducing iPSC differentiation to obtain CD34+cells and NK cells. The method utilizes the three-dimensional structure of the embryoid bodies to provide a favorable differentiation microenvironment for iPSC differentiation, and can start producing a high proportion of CD34+cells on the 4th day under hypoxic induction culture conditions. Subsequently, the production of iPSC induced NK cell differentiation is significantly increased by adhering to the embryoid bodies wall or digesting and resuspension induction, And the induced differentiation of NK cells can exert a killing effect on tumor cells in a short period of time, with strong tumor killing ability, suitable for the production and clinical application of large-scale cell preparations.Type: ApplicationFiled: August 3, 2022Publication date: February 13, 2025Applicant: ALLIFE MEDICINE (BEIJING) LIMITEDInventors: Shixin GONG, Yuchun GU, Nan LI, Mingyue JIANG, Wenhua CAO, Qinqing PENG, Lida WU -
Publication number: 20240252687Abstract: The present invention relates to gene therapy for wet age-related macular degeneration using iPSC-derived cells as vectors. CRISPR technology is used to perform site-directed dual gene editing of iPSCs, neurotrophic factors CNTF and miR-126 are expressed at the same time, and gene-edited IPSCs are then induced to differentiate into RPE cells. The RPE cells obtained by the induced differentiation can repair damaged RPE cells on CNV and inhibit the generation of choroidal neovascularization. In addition, the RPE cells can express the neurotrophic factors CNTF and miR-126 to fundamentally treat wet age-related macular degeneration, which has very good clinical application prospects.Type: ApplicationFiled: February 5, 2024Publication date: August 1, 2024Applicant: Allife Medicine (Zhuhai) LimitedInventors: Lida WU, Yuchun Gu
-
Publication number: 20240247230Abstract: Provided are a genetically modified oligodendrocyte progenitor cell, a preparation method therefor and a use thereof. Also provided is a method capable of simultaneously repairing myelin, promoting myelin production, and reducing inflammatory responses and autoimmune damage; the method comprises a genetically engineered oligodendrocyte progenitor cell achieving direct repair of a myelin sheath by means of transplantation of the genetically modified oligodendrocyte progenitor cell, which can alleviate an inflammatory response of the nerve and improve nerve function. This has very good application prospects in the clinical treatment of multiple sclerosis.Type: ApplicationFiled: February 29, 2024Publication date: July 25, 2024Inventors: Yuchun GU, Lida WU
-
Publication number: 20240240141Abstract: A rapid and efficient clinical grade pigment epithelium induction method, a kit, and an application. Provided is a method for rapidly and efficiently inducing retinal pigment epithelium (RPE). IPSCs are directionally induced in three stages, such that an RPE generation duration can be greatly shortened. Specifically, the method comprises using a culture medium containing a small molecule compound for cell culture, the small molecule compound comprising a BMP signaling pathway inhibitor, a Wnt pathway inhibitor, inhibitors for TGF-BI receptors ALK5, ALK4 and ALK7, a ROCK pathway inhibitor, a WNT signaling pathway activator, a VEGFR kinase inhibitor, a GSK signaling pathway inhibitor, a VEGFR kinase inhibitor, vitamins, and the like.Type: ApplicationFiled: February 5, 2024Publication date: July 18, 2024Applicant: ALLIFE MEDICINE (ZHUHAI) LIMITEDInventors: Lida WU, Yuchun Gu
-
Publication number: 20240207316Abstract: The present invention belongs to the field of biological medicines, and particularly relates to a chimeric receptor for improving the killing activity of immune cells and an application thereof. Specifically, the present invention provides a fusion protein. The fusion protein comprises an extracellular part, an extracellular hinge region, a transmembrane region, and an intracellular region. Most preferably, the amino acid sequence of the fusion protein of the present invention is formed by sequentially connecting SEQ ID NO.: 1, SEQ ID NO.: 3, SEQ ID NO.: 5, SEQ ID NO.: 7, SEQ ID NO.: 9 and SEQ ID NO.: 11, and the immune cells expressing the fusion protein have strong killing activity.Type: ApplicationFiled: November 21, 2023Publication date: June 27, 2024Applicant: ALLIFE MEDICINE (BEIJING) LIMITEDInventors: Lida WU, Yuchun GU
-
Publication number: 20240191205Abstract: Disclosed is an efficient and non-genetically modified iPSC-induced, industrialized single clone selection platform, and a use. The platform can efficiently perform reprogramming, and only requires the use of a minimal number of reprogramming factors (OCT4, SOX2, E6, E7). During the single clone separation stage of the present invention, SSEA4/TRA-1-60 is used as a screening marker, and a large number of single cell clones are obtained by means of flow cytometry. The platform described in the present invention has advantages such as high reprogramming efficiency, high safety, easy operation, and large-scale production.Type: ApplicationFiled: November 17, 2023Publication date: June 13, 2024Applicant: ALLIFE MEDICINE (ZHUHAI) LIMITEDInventors: Lida WU, Yuchun GU
-
Publication number: 20240093148Abstract: Provided are a method for differentiating human induced pluripotent stem cells into oligodendrocytes, and a kit and the use. The method comprises culturing stem cells by means of using at least one of the following culture media: a neural induction complete culture medium, an N2 culture medium, a B27 culture medium and an OPC maturation culture medium. More preferably, the induction of oligodendrocytes by an OPC maturation culture medium with puerarin increases the number of oligodendrocytes by 30% compared with a culture medium without puerarin.Type: ApplicationFiled: November 28, 2023Publication date: March 21, 2024Applicant: ALLIFE MEDICINE (ZHUHAI) LIMITEDInventors: Lida WU, Yuchun GU
-
Patent number: 11203663Abstract: Provided a method for separating PHA and PHA prepared therefrom. The method comprises the following steps: subjecting a PHA fermentation broth to solid-liquid separation to obtain a thallus precipitate; breaking cell walls of the thallus precipitate, and subjecting obtained wall-broken products to a plate and frame filtration to obtain PHA; a filter cloth for the plate and frame filtration is pre-coated with a PHA layer. The method adopts a plate and frame separation to replace the traditional centrifugal separation to prepare PHA, and the PHA layer is pre-coated on the filter cloth for the plate and frame filtration, thereby overcome the defects in the prior art such as high cost and operational difficulty caused by adopting multiple centrifugal separations; in addition, the method of the present disclosure also exhibits the advantages of high recovery rate of PHA and high purity of the prepared PHA product.Type: GrantFiled: December 30, 2020Date of Patent: December 21, 2021Assignees: COFCO (jilin) Bio-Chemical Technology CO., Ltd, Nutrition & Health Research Institute, COFCO Corporation, COFCO BIOTECHNOLOGY CO., LTD.Inventors: Yi Tong, Yi Li, Fang Tian, Kejia Xu, Yuanheng Guo, Bo Chen, Tai An, Dayong Li, Haijun Liu, Lida Wu
-
Publication number: 20210379548Abstract: The present invention relates to the field of high polymer material manufacturing, and discloses an air-isolated continuous feeding system for synthesizing polylactic acid from lactide and a feeding method thereof. The continuous feeding system comprises a raw material bag/box and a raw material collector for collecting and outputting lactide, the raw material bag/box is connected with a shielding gas input pipeline, a discharge pipe is movably inserted into the raw material bag/box, a cyclone separator is connected downstream of the discharge pipe, and a solid substance outlet of the cyclone separator is connected with the raw material collector. According to the invention, deterioration of the lactide raw material incurred by moisture absorption and oxidation is avoided, and the reaction conversion ratio and final product purity are improved. The continuous feeding system is easy to operate, can save manpower and material resources, and is applicable to industrial application.Type: ApplicationFiled: December 29, 2020Publication date: December 9, 2021Applicants: Nutrition & Health Research Institute, COFCO Corporation, COFCO (jilin) Bio-Chemical Technology CO., Ltd, Jilin COFCO Biomaterial Co.,Ltd, COFCO Biotechnology Co., LtdInventors: Yi TONG, Yi LI, Fang TIAN, Bo CHEN, Tai AN, Lida WU
-
Patent number: 11192079Abstract: The present invention relates to the field of high polymer material manufacturing, and discloses an air-isolated continuous feeding system for synthesizing polylactic acid from lactide and a feeding method thereof. The continuous feeding system comprises a raw material bag/box and a raw material collector for collecting and outputting lactide, the raw material bag/box is connected with a shielding gas input pipeline, a discharge pipe is movably inserted into the raw material bag/box, a cyclone separator is connected downstream of the discharge pipe, and a solid substance outlet of the cyclone separator is connected with the raw material collector. According to the invention, deterioration of the lactide raw material incurred by moisture absorption and oxidation is avoided, and the reaction conversion ratio and final product purity are improved. The continuous feeding system is easy to operate, can save manpower and material resources, and is applicable to industrial application.Type: GrantFiled: December 29, 2020Date of Patent: December 7, 2021Assignees: Nutrition & Health Research Institute, COFCO Corporation, COFCO (jilin) Bio-Chemical Technology CO., Ltd, Jilin COFCO Biomaterial Co., Ltd, COFCO Biotechnology Co., Ltd.Inventors: Yi Tong, Yi Li, Fang Tian, Bo Chen, Tai An, Lida Wu
-
Publication number: 20210340316Abstract: Provided a method for separating PHA and PHA prepared therefrom. The method comprises the following steps: subjecting a PHA fermentation broth to solid-liquid separation to obtain a thallus precipitate; breaking cell walls of the thallus precipitate, and subjecting obtained wall-broken products to a plate and frame filtration to obtain PHA; a filter cloth for the plate and frame filtration is pre-coated with a PHA layer. The method adopts a plate and frame separation to replace the traditional centrifugal separation to prepare PHA, and the PHA layer is pre-coated on the filter cloth for the plate and frame filtration, thereby overcome the defects in the prior art such as high cost and operational difficulty caused by adopting multiple centrifugal separations; in addition, the method of the present disclosure also exhibits the advantages of high recovery rate of PHA and high purity of the prepared PHA product.Type: ApplicationFiled: December 30, 2020Publication date: November 4, 2021Applicants: COFCO (jilin) Bio-Chemical Technology CO., Ltd, Nutrition & Health Research Institute, COFCO Corporation, COFCO BIOTECHNOLOGY CO., LTD.Inventors: Yi Tong, Yi Li, Fang Tian, Kejia Xu, Yuanheng Guo, Bo Chen, Tai An, Dayong Li, Haijun Liu, Lida Wu
-
Patent number: 11155483Abstract: A method for efficiently producing PHA comprising: inoculating PHA fermentation strains into a fermentation medium for fermentation under the condition of being capable of producing PHA through fermentation; subjecting the fermentation broth to a solid-liquid separation to obtain fermentation supernatant and thallus precipitate; breaking the cell walls of the thallus precipitate, and subjecting the wall-broken products to a plate and frame filtration to prepare PHA; pre-coating a filter cloth for the plate and frame filtration with a PHA layer; at least part of the water of the fermentation medium is PHA process wastewater. The method utilizes the PHA process wastewater as at least part of the water of the fermentation medium, and filters and separates the broken thallus with the plate and frame filtration equipment pre-coated with PHA layer to prepare PHA, thereby recycling the high-salt wastewater, reducing costs, and potentially separating PHA on a large scale for industrial production.Type: GrantFiled: December 28, 2020Date of Patent: October 26, 2021Assignees: Nutrition & Health Research Institute, COFCO Corporation, COFCO (jilin) Bio-Chemical Technology CO., Ltd, COFCO Biotechnology Co., Ltd., Tsinghua UniversityInventors: Yi Tong, Yi Li, Fang Tian, Weiqiang Zhou, Yuanheng Guo, Guoqiang Chen, Dayong Li, Haijun Liu, Kejia Xu, Anni Liu, Bo Chen, Tai An, Xiaoyan Wang, Chao Peng, Xuemei Shen, Jin Tao, Lida Wu, Kai Yang, Qiong Wu
-
Patent number: 11110427Abstract: The present invention relates to the technical field of polylactic acid preparation, and discloses polylactic acid polymerization reaction apparatus and system. The polylactic acid polymerization reaction apparatus comprises a polymerization reactor and an agitating assembly arranged in a flow channel of the polymerization reactor, wherein the agitating assembly comprises an electromagnetic winding mechanism and a magnetic induction element, the electromagnetic winding mechanism is arranged along the inner wall of the polymerization reactor around the magnetic induction element, with clearance formed between the electromagnetic winding mechanism and the magnetic induction element, so that the magnetic induction element and the electromagnetic winding mechanism can induce electromagnetic induction, and thereby the magnetic induction element can rotate around its own axis; a threaded groove is formed on the magnetic induction element.Type: GrantFiled: December 29, 2020Date of Patent: September 7, 2021Assignees: COFCO (JILIN) BIO-CHEMICAL TECHNOLOGY CO., LTD, JILIN COFCO BIOMATERIAL CO., LTD., COFCO BIOTECHNOLOGY CO., LTD.Inventors: Yi Tong, Yi Li, Zhigang Liu, Kejia Xu, Guoxing Zhao, Lida Wu, Kai Yang
-
Patent number: 11097248Abstract: The present invention relates to the field of devolatilization, and discloses a polylactic acid devolatilization evaporator, which comprises: a container comprising a cylinder; an agitating shaft coaxial with the cylinder; an agitating belt connected to the agitating shaft and arranged in a spiral shape around the central axis of the cylinder, comprising an outer belt surface facing the inner circumferential surface of the cylinder and spaced apart from the inner circumferential surface of the cylinder. With the above technical scheme, the agitating belt makes the materials distributed more uniformly on the inner circumferential surface of the cylinder and form a thin layer in uniform thickness, thereby avoids agglomeration of the materials, facilitates uniform heating of the materials, avoids deterioration (e.g., darkened color) of the materials owing to non-uniform heating of the materials and excessive retention time in a high-temperature environment, and improves product quality.Type: GrantFiled: December 29, 2020Date of Patent: August 24, 2021Assignees: COFCO (jilin) Bio-Chemical Technology Co., Ltd, Nutrition & Health Research Institute, COFCO Corporation, Jilin COFCO Biomaterial Co., Ltd, COFCO Biotechnology Co., Ltd.Inventors: Yi Tong, Yi Li, Kejia Xu, Bo Chen, Tai An, Fang Tian, Zhaoning Cui, Lida Wu
-
Patent number: 10822625Abstract: The present disclosure provides a method for domesticating Saccharomyces cerevisiae which is resistant to fermentation inhibitors, high temperature and high concentration of ethanol. The method comprises a primary domestication and a secondary domestication of the S. cerevisiae, wherein the primary domestication comprises the steps of replacing the fermented mash with fresh liquefied mash and continuing fermentation when the ethanol content in the fermented mash reaches a higher concentration (>12% (v/v)), the replacement is performed for at least 20 times, and the time interval of replacements is 20-30 hours; the secondary domestication comprises the steps of performing high-temperature domestication on the primary domesticated strain by a temperature gradient and replacing the fermented mash for multiple times, wherein the temperature is raised by 0.5° C.-2° C. every 18-24 times of replacement. The domesticated S.Type: GrantFiled: December 2, 2019Date of Patent: November 3, 2020Assignees: COFCO (JILIN) BIO-CHEMICAL TECHNOLOGY CO., LTD., COFCO BIO-ENERGY (ZHAODONG) CO., LTD., NUTRITION & HEALTH RESEARCH INSTITUTE, COFCO CORPORATIONInventors: Yi Tong, Yi Li, Junqi Zhang, Taibo He, Zexing Wang, Bo Hou, Hui Liu, Fan Li, Lida Wu
-
Publication number: 20200172938Abstract: The present disclosure provides a method for domesticating Saccharomyces cerevisiae which is resistant to fermentation inhibitors, high temperature and high concentration of ethanol. The method comprises a primary domestication and a secondary domestication of the S. cerevisiae, wherein the primary domestication comprises the steps of replacing the fermented mash with fresh liquefied mash and continuing fermentation when the ethanol content in the fermented mash reaches a higher concentration (>12% (v/v)), the replacement is performed for at least 20 times, and the time interval of replacements is 20-30 hours; the secondary domestication comprises the steps of performing high-temperature domestication on the primary domesticated strain by a temperature gradient and replacing the fermented mash for multiple times, wherein the temperature is raised by 0.5° C.-2° C. every 18-24 times of replacement. The domesticated S.Type: ApplicationFiled: December 2, 2019Publication date: June 4, 2020Applicants: COFCO (Jilin) Bio-Chemical Technology Co., Ltd., COFCO Bio-Energy (Zhaodong) Co., Ltd., Nutrition & Health Research Institute, COFCO CorporationInventors: Yi TONG, Yi LI, Junqi ZHANG, Taibo HE, Zexing WANG, Bo HOU, Hui LIU, Fan LI, Lida WU